Search

Author/Creator Kamimaki, Chisato

2. Afatinib + bevacizumab combination therapy in EGFR‐mutant NSCLC patients with osimertinib resistance: Protocol of an open‐label, phase II, multicenter, single‐arm trial. Issue 8 (3rd June 2020)

Authors:
Kobayashi, Nobuaki; Hashimoto, Hisashi; Kamimaki, Chisato; Nagasawa, Ryo; Tanaka, Katsushi; Kubo, Sousuke; Katakura, Seigo; Chen, Hao; Hirama, Nobuyuki; Ushio, Ryota; Aoki, Ayako; Nakashima, Kentaro; Teranishi, Shuhei; Manabe, Saki; Watanabe, Hiroki; Horita, Nobuyuki; Watanabe, Keisuke; Hara, Yu;...
Journal:
Thoracic cancer
Issue:
Volume 11:Issue 8(2020)
Page Start:
2125
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. MicroRNA‐200b is a potential biomarker of the expression of PD‐L1 in patients with lung cancer. Issue 10 (7th September 2020)

Authors:
Katakura, Seigo; Kobayashi, Nobuaki; Hashimoto, Hisashi; Kamimaki, Chisato; Tanaka, Katsushi; Kubo, Sousuke; Nakashima, Kentaro; Teranishi, Shuhei; Manabe, Saki; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Yamamoto, Masaki; Kudo, Makoto; Piao, Hongmei; Kaneko, Takeshi
Journal:
Thoracic cancer
Issue:
Volume 11:Issue 10(2020)
Page Start:
2975
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non‐small‐cell lung cancer: A multicenter retrospective trial. Issue 2 (5th December 2021)

Authors:
Matsumoto, Hiromi; Kobayashi, Nobuaki; Somekawa, Kohei; Fukuda, Nobuhiko; Kaneko, Ayami; Kamimaki, Chisato; Kubo, Sousuke; Tanaka, Katsushi; Tagami, Yoichi; Teranishi, Shuhei; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Yamamoto, Masaki; Kudo, Makoto; Koizumi, Harumi; Miura, Kenji; Miyazawa, N...
Journal:
Thoracic cancer
Issue:
Volume 13:Issue 2(2022)
Page Start:
228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis. Issue 7 (9th February 2021)

Authors:
Kobayashi, Nobuaki; Katakura, Seigo; Kamimaki, Chisato; Somekawa, Kohei; Fukuda, Nobuhiko; Tanaka, Katsushi; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Piao, Hongmei; Kaneko, Takeshi
Journal:
Thoracic cancer
Issue:
Volume 12:Issue 7(2021)
Page Start:
1096
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. T‐cell response to phytohemagglutinin in the interferon‐γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non‐small cell lung cancer. Issue 11 (4th May 2021)

Authors:
Kamimaki, Chisato; Kobayashi, Nobuaki; Hirata, Momo; Somekawa, Kohei; Fukuda, Nobuhiko; Kubo, Sousuke; Katakura, Seigo; Teranishi, Shuhei; Watanabe, Keisuke; Horita, Nobuyuki; Hara, Yu; Yamamoto, Masaki; Kudo, Makoto; Piao, Hongmei; Kaneko, Takeshi
Journal:
Thoracic cancer
Issue:
Volume 12:Issue 11(2021)
Page Start:
1726
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗